On 20 November 2018 JPND announced a new ERA-NET Cofund project, JPcofuND2, established under the European framework programme for investigation and innovation H2020, which continues the work of the JPcofuND project (2014-2019) and other activities pursued by the European joint programming initiative on neurodegenerative diseases research (for more information please check JPND's page in FCT's website).
JPcofuND2 is implemented between 2019 and 2023, and its major activities are:
The following countries are part of JPcofuND 2: France; Finland; Canada*; Israel; Germany; Portugal (FCT and Regional Fund for Science and Technology of the Azores); Austria; Luxembourg; Belgium; Ireland; Denmark; Spain; Czech Republic; Italy; Slovenia; United Kingdom; Poland; Hungary; Norway; Switzerland; Sweden; Turkey; Latvia; Netherlands. *does not receive EC funding
On this page you can consult information about JPcofuND 2, namely:
UNDERSTANDING THE MECHANISMS OF NON-PHARMACOLOGICAL INTERVENTIONS
Please check JPcofuND2's CTC 2022 call text for detailed information on participating countries, aim of the call, management, eligibility, funding regulation and application, among other relevant information.
For more information, please check call documentation, national documentation and relevant links in the yellow box on the right.
Proposals must focus on one or several of the following neurodegenerative diseases:
See the list of participating countries on the JPcofuND2 CTC 2022 page.
FCT's funding commitment for JPcofuND2's CTC 2022: €150,000.00 (one hundred and fifty thousand Euros).
Note: if more than one Portuguese institution participates in a given consortium, the budget has to be shared. Portuguese institutions must follow FCT's Legislation, Regulations and Norms. The dedication (FTE) in transnational projects is not taken into account for the 100% (FTE) dedication to national projects.
The regulation applicable to projects to be funded by FCT is the Regulation on Projects Funded Solely by National Funds.
Note: the information contained in this page does not exempt from reading the call text, nor the other documents related to the call or the application process, constituting only a summary of them. No information contained in this page replaces or supersedes what is stipulated in the call text, in its procedures or in any other document of the call presented in the webpage of the CTC 2022 of JPcofuND2.
JPcofuND2 Joint Transnational Call 2021 supported a number of ambitious, innovative, multi-disciplinary and multi-national collaborative research projects that aimed at identifying and measuring physiological effects and related biomarkers that could be linked to the development of neurodegenerative diseases, as well as enhancing the understanding of causal underlying cellular, molecular, metabolic, inflammatory or other systemic processes.
Proposals focused on one or more of the following neurodegenerative diseases:
Twenty-three national and regional agencies from JPND countries participated in the competition.
You can find more information about this contest on the call page on the JPND website.
For more information on this and other projects funded under the JPcofuND2 JTC 2021 please check the results of the call in the JPcofuND2 JTC 2021 results page.
This project receives funding from the European Union's Horizon 2020 research and innovation programme under grant agreement no. 825664.